Keyphrases
Response Regulator
100%
DNA Damage Response
100%
Phosphoproteomics
100%
New Biomarkers
100%
Berzosertib
100%
ATR Inhibitor
100%
Highly Sensitive
66%
Phosphorylation
66%
RNA Polymerase II (RNAPII)
66%
Genome Maintenance
66%
SCAF1
66%
Anticancer Drugs
33%
Clinical Trials
33%
DNA Damage
33%
Tumor Suppressor
33%
Mass Spectrometry
33%
Breast Cancer Susceptibility Gene 1 (BRCA1)
33%
Genotoxic Agents
33%
RAD51
33%
Monotherapy
33%
ATR Kinase
33%
DNA Replication Stress
33%
Secondary Screening
33%
Advanced Solid Tumors
33%
Maintenance Factor
33%
PARP Activity
33%
DNA Damage Stress
33%
Proteomic Screening
33%
Biochemistry, Genetics and Molecular Biology
DNA Damage Response
100%
DNA Damage
100%
Phosphoproteomics
100%
Anticancer
50%
Clinical Trial
50%
Phosphotransferase
50%
Tumor Suppressor Protein
50%
Kinase
50%
DNA Synthesis
50%
Mass Spectrometry
50%
BRCA1
50%
RAD51
50%
Poly ADP Ribose Polymerase
50%
Proteomics
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Berzosertib
100%
Solid Malignant Neoplasm
25%
Anticarcinogen
25%
Clinical Trial
25%
Tumor Suppressor Protein
25%
Monotherapy
25%
ATR Protein
25%
MinD Protein
25%